Female Infertility

Medical Analysis

Comprehensive Guide to Female Infertility: Clinical Pillars, Diagnostics, and Patient Management

Female infertility is a clinical condition defined by the inability to achieve a clinical pregnancy after one year of regular, unprotected intercourse [1]. For women aged 35 and older, this clinical window for evaluation is reduced to six months [1]. Female factors contribute to approximately 40% of all infertility cases, and it is common for male and female fertility factors to coexist [1, 15]. Proper diagnosis relies on a systematic, evidence-based approach, which is organized into five critical pillars: checking for regular ovulation, assessing ovarian reserve, ensuring fallopian tube patency, evaluating the uterine cavity, and identifying systemic or hormonal issues [1, 15].

The Five Pillars of Female Infertility

The diagnostic workup for female infertility is built upon five foundational pillars designed to identify reproductive barriers [1, 15]:

• Pillar 1: Regular Ovulation: Ensuring the consistent release of a healthy egg [1].

• Pillar 2: Ovarian Reserve: Assessing the quantity and quality of remaining eggs [2, 4].

• Pillar 3: Fallopian Tube Patency: Ensuring the fallopian tubes are open to allow for fertilization [1, 8].

• Pillar 4: Uterine Cavity Evaluation: Checking the uterus for structural abnormalities like polyps, fibroids, or scars [7, 9].

• Pillar 5: Systemic and Hormonal Assessment: Identifying metabolic or hormonal imbalances that disrupt fertility [13, 15].

Clinical Assessment of Ovulation (Pillar I)

Ovulation assessment is critical to confirm the release of a healthy egg [1].

• Mid-luteal progesterone testing: This is considered the most important diagnostic test for ovulation. Levels above 3 ng/mL confirm that ovulation has occurred [1].

• Ovulation Predictor Kits (OPKs): These kits detect the Luteinizing Hormone (LH) surge in urine. An LH surge typically indicates that ovulation will occur within 12 to 36 hours. These kits are highly effective, with accuracy reaching up to 99% [1].

• Basal Body Temperature (BBT): While a historical method, tracking waking temperature can show a post-ovulation rise of approximately 0.5°F to 1°F, which remains sustained until the next menstrual period [1].

• Serial Transvaginal Ultrasound: This is the gold standard for tracking follicular growth and rupture [7].

• Cervical Mucus Monitoring: Observing changes to stretchy, clear cervical mucus can help identify a woman’s fertile window [1].

Ovarian Reserve Assessment (Pillar II)

Assessing the ovarian reserve helps predict the response to fertility treatments [4].

• Anti-Müllerian Hormone (AMH): This is currently considered the best marker for egg quantity, as levels remain relatively stable throughout the menstrual cycle [3, 14].

• Day 3 FSH and Estradiol: Elevated FSH levels on day 3 of the cycle suggest a diminished ovarian reserve [2, 4]. Estradiol is often measured alongside FSH for more accurate clinical interpretation [4].

• Antral Follicle Count (AFC): Performed via transvaginal ultrasound, this counts the visible follicles in the ovaries to assess reserve [2, 4].

Tubal and Uterine Assessment (Pillar III & IV)

Evaluating the environment for conception involves both the fallopian tubes and the uterine cavity [1, 9].

• Hysterosalpingography (HSG): An X-ray procedure using contrast dye to visualize the uterine shape and confirm fallopian tube patency. It is typically performed during the follicular phase [8].

• Saline Sonography (SIS): Combines ultrasound and saline to evaluate the uterine cavity for polyps, fibroids, or structural scars [7].

• Hysteroscopy: Allows direct visualization of the uterine interior for diagnostic and potential therapeutic purposes [7].

• Laparoscopy: Considered the gold standard for assessing tubes. Chromopertubation during laparoscopy confirms if tubes are truly open and can identify external pelvic adhesions or endometriosis [1, 15].

Systemic and Hormonal Assessment (Pillar V)

Addressing systemic health is essential for restoring fertility [13, 15].

• Thyroid Function (TSH): Essential to check for hidden thyroid disorders that may disrupt regular ovulation cycles [13].

• Prolactin Levels: Assesses pituitary gland function; elevated prolactin can prevent normal egg release [1, 15].

• Androgen Levels: DHEAS and Testosterone screening are used to identify androgen excess, which often points toward a PCOS diagnosis [5].

• Metabolic Screening: Fasted insulin and HbA1c levels are used to check for metabolic insulin resistance or undiagnosed diabetes, especially in PCOS workups [5].

• Vitamin D: Levels are evaluated as they impact overall reproductive health [15].

Master Table of the Five Pillars of Female Infertility

Additional Specialized and Genetic Testing

When standard workups do not yield clear results or in cases of recurrent pregnancy loss, advanced testing may be required [11, 12].

• Immunological & Infectious Testing: Screening for infections such as Chlamydia trachomatis (IgG) is vital, as infections can cause tubal damage [10]. Antiphospholipid antibodies (APLA) and Antinuclear Antibodies (ANA) are tested in cases of recurrent loss [11, 12].

• Endometrial Assessment: A biopsy, particularly using CD138 staining to identify plasma cells, can diagnose Chronic Endometritis—a persistent, silent inflammation of the uterus that creates a hostile environment for implantation [10].

• Genetic Testing: Indications include recurrent miscarriage, primary ovarian insufficiency (POI) before age 40, or a family history of early menopause/intellectual disability [6, 11]. Specific tests may include Karyotyping, Fragile X (FMR1 gene) testing, and CFTR gene mutation analysis [6, 11].

For Non-Medicos: Understanding Your Fertility Journey

If you have been trying to get pregnant for a year (or six months if you are 35 or older) without success, it is time to consult a fertility specialist [1]. Infertility is a medical condition, not a personal failure, and it is often manageable through systematic testing and targeted treatments [1, 15].

How We Find the Cause

Fertility doctors look at five main areas, often called “pillars,” to understand your fertility status [1, 15]:

• Ovulation: We check if your body is regularly releasing a healthy egg [1]. Tests like blood work for progesterone or simple urine-based kits at home can show this [1].

• Egg Supply: We measure your “ovarian reserve” to estimate how many eggs you have left [4]. Common tests include AMH blood tests and ultrasound counts of follicles [2, 3].

• Tubal Health: We need to make sure your fallopian tubes—the bridge between your ovaries and your uterus—are open [8]. This is usually checked with an X-ray test called an HSG [8].

• Uterine Health: We look for things inside the uterus like polyps or fibroids that might block an embryo from implanting [7, 9].

• Overall Health: Hormone imbalances (like thyroid issues) or metabolic problems (like insulin resistance) can prevent pregnancy [5, 13]. Simple blood tests help us identify and fix these issues [15].

Important Steps to Remember

• Timing Matters: For many tests, the timing within your cycle is crucial [1]. For example, hormone levels like FSH and Estradiol are often checked during the first few days of your period [4].

• No “One Size Fits All”: Not every woman needs every test [15]. Your doctor will choose tests based on your personal health history, age, and symptoms [15].

• Advanced Needs: If you have experienced recurrent miscarriages, your doctor may suggest advanced genetic or immune-related testing to rule out deeper causes [11, 12].

Taking the step to get evaluated is the most important part of your journey toward motherhood [1, 15]. Working with a dedicated team—including gynecologists, endocrinologists, and nutritionists—helps create a “multiple approaches with single target” plan to help you achieve a healthy pregnancy [15].

References:

1. Practice Committee of the American Society for Reproductive Medicine. (2015). Diagnostic evaluation of the infertile female: a committee opinion. Fertility and Sterility, 103(6), e44-e50.

2. Steiner, A. Z., & Jukic, A. M. (2016). Clinical significance of markers of ovarian reserve. Current Opinion in Obstetrics and Gynecology, 28(3), 148-153.

3. Kelsey, T. W., Wright, P., Nelson, S. M., Anderson, R. A., & Wallace, W. H. (2011). A validation of a model of low anti-Müllerian hormone levels for the prediction of poor ovarian response to controlled ovarian stimulation. Human Reproduction, 26(6), 1548-1554.

4. Broekmans, F. J., Kwee, J., Hendriks, D. J., Mol, B. W., & Lambalk, C. B. (2006). A systematic review of tests predicting ovarian reserve and IVF outcome. Human Reproduction Update, 12(6), 685-718.

5. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility, 81(1), 19-25.

6. Simpson, J. L. (2008). Genetic causes of primary ovarian insufficiency. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 148(1), 21-29.

7. Saunders, R. D., Shwayder, J. M., & Nakajima, S. T. (2011). Diagnosing uterine pathology: the relative merits of transvaginal sonography, saline infusion sonography, and hysteroscopy. American Journal of Obstetrics and Gynecology, 205(2), 120-e1.

8. Simpson, W. L., Beitia, L. G., & Mester, J. (2006). Hysterosalpingography: a reemerging study. Radiographics, 26(2), 419-431.

9. Taylor, E., & Gomel, V. (2008). The uterus and fertility. Fertility and Sterility, 89(1), 1-16.

10. Eckert, L. O., Thwin, S. S., Hillier, S. L., Kipp, W., & Agnew, K. J. (2002). The immunopathology of endometrial inflammation and chronic endometritis. American Journal of Obstetrics and Gynecology, 187(6), 1563-1568.

11. Practice Committee of the American Society for Reproductive Medicine. (2012). Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertility and Sterility, 98(5), 1103-1111.

12. Kutteh, W. H. (2015). Novel strategies for the management of recurrent pregnancy loss. Seminars in Reproductive Medicine, 33(3), 161-168.

13. Krassas, G. E., Poppe, K., & Glinoer, D. (2010). Thyroid function and human reproductive health. Endocrine Reviews, 31(5), 702-755.

14. Luciano, A. A., Peluso, J. J., Koch, E. I., & Maier, D. B. (1990). Temporal stability of serum anti-Müllerian hormone levels during the menstrual cycle. The Journal of Clinical Endocrinology & Metabolism, 70(4), 1102-1105.

15. Schorge, J. O., Schaffer, J. I., Halvorson, L. M., Hoffman, B. L., Bradshaw, K. D., & Cunningham, F. G. (2008). Williams Gynecology. McGraw-Hill Medical.

FAQ’s:

• How is female infertility defined?
  It is the absence of pregnancy after one year of regular, unprotected intercourse, or six months if aged over 35.

• What percent do female factors cause?
  Female factors cause 40% of cases, though male and female reproductive factors often coexist during clinical evaluations.

• What confirms that ovulation occurred?
  Mid-luteal progesterone serum levels measured strictly above 3 ng/mL confirm that ovulation successfully occurred during the cycle.

• What is the ovulation gold standard?
  Serial transvaginal ultrasound is the gold standard used to track follicular growth and rupture directly in real-time.

• Which marker best measures egg quantity?
  Anti-Müllerian Hormone (AMH) serves as the best clinical marker for egg quantity and remains stable throughout the cycle.

• What does high Day 3 FSH mean?
  Early follicular FSH values greater than 10-15 mIU/mL signal a significantly diminished or poor ovarian reserve.

• When is an HSG performed? An
  Hysterosalpingography (HSG) contrast dye test is strictly performed during the follicular phase to safely evaluate tubal patency.

• What diagnoses chronic endometritis?
  Advanced CD138 immunohistochemical staining identifies specific plasma cells to accurately diagnose silent chronic endometritis uterine inflammation.

• When should genetic testing be ordered?
  Order genetic testing after two or more unexplained pregnancy losses or a primary ovarian insufficiency diagnosis before age 40.

• What is tested on cycle days 2-5?
  FSH, LH, Estradiol, and AMH are tested during this early follicular phase to assess a patient’s ovarian reserve.

Related Tests

• Serum Progesterone Test

• Anti-Müllerian Hormone (AMH) Test

• Estradiol (E2) Test

• Thyroid-Stimulating Hormone (TSH) Test

• Prolactin Test

• HbA1c Test